Onuma Yuki, Yoshida Tomohiko, Matsuura Katsuhiro, Aboshi Yuki, Hasegawa Mizuki, Yamada Shusaku, Yaginuma Youta
VCA Japan Shiraishi Animal Hospital, Sayamadai, 4-33-2, Sayama 350-1304, Saitama, Japan.
VCA Japan Ozenji Pet Clinic, Ozenjinishi 3-27-1, Asaoku, Kawasaki 215-0017, Kanagawa, Japan.
Vet Sci. 2024 May 5;11(5):201. doi: 10.3390/vetsci11050201.
Myocardial protection has become an essential adjunctive procedure in veterinary cardiac surgery. Del Nido cardioplegia is a good alternative to the traditional St. Thomas II (ST) cardioplegia in open heart surgery in humans. This study aims to compare intra- and postoperative results between ST cardioplegia and modified del Nido (mDN) cardioplegia in mitral valve surgery in dogs with myxomatous mitral valve disease (MMVD). This retrospective study was conducted using clinical records of 16 MMVD dogs that underwent either ST or mDN cardioplegia. We measured cardiopulmonary bypass (CPB) time, aortic cross-clamp (ACC) time, total operation time, the number of cardioplegia doses, total amount of cardioplegia, required defibrillations, in-hospital mortality and pre- and one-month postoperative echocardiographic variables. CPB (159.4 ± 16.1 vs. 210.1 ± 34.0 min), ACC (101.4 ± 7.0 vs. 136.0 ± 24.8 min) and total operation time (262.3 ± 13.1 vs. 327.0 ± 45.4 min) were significantly shorter in the mDN group ( < 0.05). The number of cardioplegia doses (3.25 ± 0.4 vs. 6.25 ± 1.2) and total amount of cardioplegia (161.3 ± 51.5 vs. 405.0 ± 185.9 mL) in the mDN group were also significantly smaller than the ST group ( < 0.05). No difference was observed in the requirement of defibrillation, in-hospital mortality and pre- and postoperative echocardiographic variables. The utilization of mDN cardioplegia was associated with shorter operative time in mitral valve surgery in dogs.
心肌保护已成为兽医心脏手术中必不可少的辅助程序。在人类心脏直视手术中,德尔尼多停搏液是传统圣托马斯II号(ST)停搏液的良好替代品。本研究旨在比较患有黏液瘤性二尖瓣疾病(MMVD)的犬二尖瓣手术中ST停搏液和改良德尔尼多(mDN)停搏液的术中和术后结果。本回顾性研究使用了16只接受ST或mDN停搏液治疗的MMVD犬的临床记录。我们测量了体外循环(CPB)时间、主动脉阻断(ACC)时间、总手术时间、停搏液剂量、停搏液总量、所需除颤次数、住院死亡率以及术前和术后1个月的超声心动图变量。mDN组的CPB时间(159.4±16.1 vs. 210.1±34.0分钟)、ACC时间(101.4±7.0 vs. 136.0±24.8分钟)和总手术时间(262.3±13.1 vs. 327.0±45.4分钟)显著更短(<0.05)。mDN组的停搏液剂量(3.25±0.4 vs. 6.25±1.2)和停搏液总量(161.3±51.5 vs. 405.0±185.9毫升)也显著低于ST组(<0.05)。在除颤需求、住院死亡率以及术前和术后超声心动图变量方面未观察到差异。在犬二尖瓣手术中,使用mDN停搏液与较短的手术时间相关。